What you should know:
1. The new clearance covers new system instrumentation and an updated surgical technique.
2. The FDA initially cleared the device in October 2018.
3. SpineEX expects to begin offering the Sagittae system commercially by the end of March.
4. SpineEX CEO and Chairman Roy Chin said, “We expect, in the very near future, to announce the first procedure using our innovative Sagittae device to be performed by a leading orthopedic surgeon and complete our transition from a development stage to a commercial stage and revenue generating company.”
More articles on devices:
The spine surgery devices, techniques that won’t stand the test of time
How spine surgeons view consolidation in healthcare
4 spine, neurosurgeons on the move in February
